Trial Profile
Study evaluating stress perfusion cardiac MRI using Regadenoson to detect Microvascular Dysfunction in children with Hypertrophic Cardiomyopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2018
Price :
$35
*
At a glance
- Drugs Regadenoson (Primary)
- Indications Coronary disorders
- Focus Diagnostic use
- 16 Oct 2018 New trial record